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EFFECT OF HOLOTHURIN ON SARCOMA 180 AND B-16 
MELANOMA TUMORS IN MICE' 
bY 
S. D. CAIRNS2 and C. A. OLMSTED 
Department of Biological Sciences, Louisiana State 
University in New Orleans, Louisiana 70122 
ABSTRACT 
Holothurin, a biotoxic principle from the Cuvierian glands of the 
Bahamian sea-cucumber, Actinopyga agassixi, was studied as an anti- 
tumor agent capable of retarding tumor growth and prolonging the 
life of tumor-bearing mice. White Swiss mice injected with Sarcoma 
180 had a mean survival time of 18.1 days with an average weight 
gain representing tumor and ascites fluid accumulation amounting to  
25.1 grams in 15 days. Of five white Swiss mice with Sarcoma 180 re- 
ceiving 0.15 mg Holothurin every other day, one was alive a t  57 days 
and the average weight gain of the group was 10.4 grams in 15 days. 
White Swiss mice with Sarcoma 180 which survived the lethal effects 
of slightly higher doses of Holothurin also had prolonged survival 
times and negligible tumor growth. C57-Bl-6J mice with B-16 mela- 
noma tumors did not show increased survival time using the same 
doses of Holothurin that were effective in white Swiss mice. Toxicity 
tests indicated that the safe upper limit for intraperitoneal Holothurin 
injection in white Swiss mice was 0.10 mg/day, 0.15 mg given every 
other day, and up to 0.30 mg given in a single injection. Similar tests 
with C57 black mice showed survival with as much as 0.60 mg Holo- 
thurin in a single subcutaneous injection. Holothurin was found to be 
250 to 500 times more effective in causing red blood cell hemolysis 
than saponin and thus appears to have some action on living cells in 
addition t o  its surfactant action. 
INTRODUCTION 
Cancer chemotherapy began in 1946 when nitrogen mustard was 
used in treating leukemia patients. During the next 15 years only some 
thirty drugs were used in cancer chemotherapy but screening of many 
thousands of compounds was carried out each year (Clark 1961). Al- 
though marine invertebrates provide a particularly rich source of 
compounds with biological activity in mammalian species, less than 
1 This work was supported in par t  by the Cancer Association of Greater New 
Orleans, Inc. 
2 Present address : Department of Biological Oceanography, the Rosenstiel 
School of Marine and Atmospheric Sciences, University of Miami, Miami, Florida 
33129. 
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17. of all marine invertebrates thought to possess biotoxic substances 
have been investigated and of those, only a dozen have been thorough- 
ly investigated pharmacologically (Halstead 1965) . 
Small concentrations of a crude water extract made from the 
whole body of the Bahamian sea-cucumber, Actinopyga agassixi, was 
found to  be lethal t o  mice and fish and to  have some tumor cell inhibi- 
tory action in vitro (Nigrelli and Zahl 1952). The active principle of 
this crude extract was found to be concentrated in the Cuvierian tub- 
ules located in the sea-cucumber respiratory tree and was named Holo- 
thurin (Chanley et al. 1955). Holothurin was the first known steroid 
saponin of animal origin (Nigrelli et al. 1959). Chemical analysis of 
Holothurin indicates that it is highly soluble in water, non-volatile, 
heat stable, and exhibits surface-active properties (Nigrelli and Ja- 
kowska 1960). Holothurin appears to consist of a few steroid agly- 
cones that are bound individually to four monosaccharide molecules. 
A provisional formula has been proposed (Alender and Russell 1966). 
See Fig. 1. 
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Figure 1. Holothurin formula. Proposed structure for Holothurin mole- 
cule, a steroid saponin of animal origin; the monosaccharide groups rep- 
resented by SI-S4 are, respectively, D-glucose, D-xylose, D-quinovose, and 
3-o-methyl glucose. 
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Holothurin is highly toxic to many types of organisms in very 
small concentrations. I t  retards onion root tip development (Nigrelli 
and Jakowska 1960) and fruit fly pupation (Goldsmith, Osburg and 
Nigrelli 1958) a t  1000 ppm, alters regeneration of planarians a t  100 
ppm (Quaglio et al. 1957), is lethal to the “pearl” fish Caiapiis a t  
1 ppm and affects sea urchin development at 0.01 ppm (Ruggieri and 
Nigrelli 1960). Holothurin exhibits a hemolytic effect on red blood 
cells and reduces the size of a subcutaneously injected Sarcoma 180 
tumor in white Swiss mice (Nigrelli 1952). Krebs-2 ascites tumors in 
white Swiss mice are also inhibited by Holothurin (Sullivan, Ladue 
and Nigrelli 1955). 
The present study demonstrates inhibition of Sarcoma 180 tu- 
mors in white Swiss mice but not of B-16 melanoma tumors in C57 
Black 6J  mice. Toxicity of Holothurin was estimated by measuring its 
effects on red blood cell hemolysis and by lethal-dose measurements in 
mice. It appears that the anti-tumor activity of Holothurin is not only 
dose-dependent but that the effective dose is determined by the sensi- 
tivity of the species to the lethal effects of Holothurin. 
MATERIALS AND METHODS 
Holothurin: The Holothurin referred to in this paper was a 
“crude extract’’ obtained from Dr. Ross Nigrelli and was made from 
the sun-dried, powdered Cuvierian glands of Bahamian sea-cucum- 
bers, Actinopvga ayassixi. 
Red Blood Cell Hemolysis Tests Us ing  Holothtwi?t arid Sapo?iin : 
Fresh red blood cells were obtained from white Swiss mice just prior 
to testing the hemolytic effects of Holothurin and saponin of plant 
origin. The blood was obtained by cardiac puncture while the mice 
were under light ether anesthesia. Approximately 5 ml of blood was 
diluted in 100 ml of balanced-saline solution buffered at pH 7.4 (Olm- 
sted 1967) containing calcium oxalate (0.1 ) to prevent coagulation. 
A serial dilution of Holothurin was prepared ranging from 2 mg/ml 
to 0.001 mg/ml and a similar series of dilutions of saponin was made 
for comparison. 
One ml of diluted blood was added to 5 ml of each of several con- 
centrations of both Holothurin and saponin. The test tube was centri- 
fuged 1 minute after mixing the contents and the optical density of 
the supernatant was measured using a spectrophotometer set at 540 
mu. The degree of hemolysis was estimated by the concentration of 
hemoglobin in the supernatant. These values were compared to 100% 
hemolysis values obtained either by using water only as the diluent or 
by using a high concentration of Holothurin or saponin. 
Holothzwin Toxicity i)z Mice  : All Holothurin injections were 
given at dosages determined by previous tests done in this laboratory 
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on normal, non-tumor-bearing mice. Tests to determine the lethal and 
sub-lethal intraperitoneal doses of Holothurin in white Swiss mice 
were carried out using several concentrations given daily, given on 
alternate days, and for several concentrations given in a single injec- 
tion. The dosages of Holothurin given to the white Swiss mice bearing 
Sarcoma 180 tumors were based on these data. The dosages of Holo- 
thurin given to the C57 black mice bearing B-16 melanoma tumors 
was based on the effective doses of Holothurin given to tumor-bearing 
white Swiss mice. In addition, a test of toxicity of a single subcuta- 
neous injection of Holothurin was carried out using several concentra- 
tions of Holothurin given to normal, non-tumor-bearing C57-Bl-6J 
mice. 
Holothurin Administration t o  Mice Bearing Sarcoma 180: Sar- 
coma 180 cells and the white Swiss mice were obtained from the Gulf 
South Research Institute in New Orleans. The mice were inoculated 
intraperitoneally with 0.5 ml of Sarcoma 180 ascites fluid containing 
11.6 X l o6  cells/ml. Groups of five mice received daily injections of 
Holothurin a t  0.01, 0.05, 0.10, and 0.15 mg each, and three groups re- 
ceived injections of Holothurin every other day in the amounts of 
0.10, 0.15 and 0.20 mg each. Twelve mice received Sarcoma 180 inocu- 
lations, but no Holothurin. The survival time was recorded for each 
mouse and the mice were weighed individually before inoculation with 
tumor cells and a t  &day intervals during the course of the experi- 
ments. 
Holothurin Administration t o  Mice Bearing €3-1 6 Melanoma : A 
single C57-Bl-6J mouse with a B-16 melanoma tumor was used as the 
source for all of the B-16 melanoma used in this study. The tumor- 
bearing donor mouse was obtained from the Department of Surgery 
at Tulane Medical School. The C57-Bl-6J mice used in the experi- 
ments here were obtained from the Roscoe B. Jackson Memorial Lab- 
oratory in Bar Harbor, Maine. The solid tumor was taken from the 
donor mouse under light ether anesthesia and was minced with scis- 
sors in a tissue culture nutrient medium containing serum (Olmsted 
1967). Several small pieces of the minced tumor were trochared sub- 
cutaneously into the left side of thirty-five recipient male mice. Thirty 
of these mice were used for the experiments reported here. Daily in- 
jections of 0.05, 0.10, and 0.15 mg Holothurin were given to each of 
the five tumor-bearing mice in three groups and five tumor-bearing 
mice in another group were each given 0.20 mg Holothurin every 
other day. Five mice without melanoma, and ten mice with melanoma 
tumors, were also maintained but not given Holothurin. All Holo- 
thurin injections were given subcutaneously near the region of tumor 
implantation in 0.10 ml volumes, and were given over a 13-day period. 
The survival time was recorded for each mouse, and the mice were 
weighed in groups of five before tumor implantation and at &day in- 
tervals during the course of the experiments. 
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F 
F 
F 
F 
F 
F 
F 
M 
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Dose 
(ma)  
0 
0.01 
0.05 
0.10 
0.10 
0.15 
0.15 
0.20 
RESULTS 
Hemolysis Tests : Minimum concentrations of Holothurin and 
saponin that produced complete hemolysis were found to be 0.001 
mg/ml of Holothurin and 0.25-0.50 mg/ml of saponin indicating that 
Holothurin was 250 to 500 times more active as a hemolytic agent 
than saponin. 
Holothurin Toxicity in Mice : Holothurin treatment of tumor- 
bearing white Swiss mice at  the level of 0.15 mg/day was lethal at 3 
t o  8 days with a mean of 4.2 days. See Table 1. Toxicity tests on other 
Table 1. 
Effects of Holothurin on White Swiss Mice with Sarcoma 180 
No. 
of 
Mice 
12 
5 
5 
5 
5 
5 
5 
5 
-
Frequency 
of 
i n  j ect i o n  
0 
d a i l y  
d a i l y  
d a i l y  
a l t e r n a t e  
days 
a l t e r n a t e  
days 
d a i l y  
alternate 
days 
S u r v i v a l  
T i m e  
(days)  
18.1 
(15-2 1) 
19.2 
(15-22) 
17.8 
(16-23) 
16.3 
(14-19) 
16.8 
(15-20) 
26.4 
(16-58) 
4.2 
(3-8) 
22.2 
(10-47) 
Bod7 
5th 
day 
(g> 
+2.3 
+2.0 
0 
-1.4 
-1.1 
-1.0 
d i e d  
-1.8 
Weight 
1 0 t h  
day 
& 
+13.0 
+12.7 
+13.8 
+ 8.2 
+lo. 1 
+ 2.9 
-- 
0 
:hange 
15th 
day 
.(g> 
-25.1 
127.6 
k33.0 
k30.7 
t29.4 
i-10.4 
-- 
0 
groups of normal, non-tumor-bearing white Swiss mice indicated that 
either 0.10 mg/day or 0.15 mg given on alternate days was a safe 
upper limit for intraperitoneal Holothurin administration. Addition- 
ally, 0.30 mg Holothurin in a single injection could be tolerated, but 
more than this amount in a single injection was lethal. Toxicity tests 
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on C57-Bl-6J mice without B-16 melanoma tumors indicated that 
these mice could survive single subcutaneous injections of Holothurin 
as high as 0.60 mg. 
EfSect o f  Holothurin on White Swiss Mice wi th  Sarcoma 180:  
Twelve tumor-bearing mice that were not treated with Holothurin 
lived for an  average of 18.1 days after tumor cell inoculation. These 
mice gained an  average of 25.1 g by the fifteenth day after tumor cell 
inoculation. This increase in body weight represents the extent of in- 
crease in tumor size and ascites fluid accumulation since body weight 
increase due to growth of the animal during this time would have 
been negligible. The tumor-bearing animals receiving 0.15 mg Holo- 
thurin on alternate days had a mean survival time of 26.4 days repre- 
senting an  increase in survival time of 46%, and a mean weight gain 
a t  15 days of 10.4 g representing a 60 to 70% decrease in tumor 
growth and ascites fluid accumulation. One of the mice in this high 
Holothurin dose group had a weight gain of only 5.1 g and was still 
alive after 58 days. Three of the mice receiving 0.20 mg Holothurin 
every other day died in less than 12 days probably as a result of Holo- 
thurin overdose. Of the other two mice in the 0.20 mg group, one 
lived for 30 days and the other for more than 47 days and both had 
negligible weight gain during this period of time indicating complete 
tumor suppression. The four groups of tumor-bearing mice receiving 
less than 0.15 mg of Holothurin per injection did not show any sig- 
nificant increase in survival time or decrease in weight gain. See 
Table 1. 
EfSects of Holothurin on C57-Bl-6J Mice with B-16 Melanoma: 
Ten C57-Bl-6J mice not injected with Holothurin lived for an average 
time of 29.4 days after B-16 melanoma inoculation with a range of 
18 to 43 days. The animals with malignant melanoma tumors de- 
creased in total body weight. Normal, non-tumor-bearing C57-Bl-6J 
mice of comparable age to the tumor-bearing mice all gained weight 
on the diet and the conditions'of this experiment. Measurement of 
body weight was not a valid indicator of tumor growth or of Holo- 
thurin effectiveness, as in the case of mice with Sarcoma 180, because 
the melanoma tumor grows in a small solid mass and does not induce 
ascites fluid accumulation. As the Holothurin dosages used here were 
comparable to the effective doses for white Swiss mice bearing Sar- 
coma 180 tumors, and were well below the toxic levels of Holothurin 
for C57-Bl-6J mice, none of the animals in this experiment showed 
any increase in the survival time. See Table 2. 
DISCUSSION 
The crude extract of Holothurin used here was probably more 
potent than purified preparations would be. Upon purification, the 
anti-tumor principle is apparently lost or considerably reduced in con- 
- 
No.  
of 
Mi CE 
10 
5 
5 
5 
5 
-
- 
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Table 2. 
Effects of Holothurin on C57-Bl-6J Mice with Melanoma 
- 
Sei 
I 
M 
M 
M 
M 
M 
- 
Dose 
(ma)  
0 
0.05 
0.10 
0.15 
0.20 
I 
L 
1
Frequency 
of 
i n  j ec t ion 
0 
d a i l y  
d a i l y  
d a i l y  
, alternate 
~ days 
I 
S u r v i v a l  
T i m e  
(days)  
29.4 
(18-43) 
25.6 
(20-42) 
22.7 
(19-26) 
24.4 
(20-35) 
29.6 
(25-33) 
I I 
Body 
5 t h  
day 
0 
t o . 4  
-1.1 
-4.1 
-3.1 
-2.6 
Weigh 
10 th  
day 
(g> 
-0.7 
-3.4 
-4.8 
-3.5 
-3.5 
day 
(g> 
-0.8 
-3.5 
-5.4 
-4.3 
-3.6 
e - 
20th  
day 
(g> 
-0.3 
-2.5 
-4.4 
-4.5 
-3.3 
- 
centration (Chanley et al. 1960). One sample of purified Holothurin 
showed a tenfold-loss in hemolytic activity, and no anti-tumor activ- 
ity (Nigrelli and Jakowska 1960). 
Although the crude extract of Holothurin is effective against var- 
ious tumors (Nigrelli 1952, and Sullivan, Ladue and Nigrelli 19551, 
the present study demonstrates that Holothurin is apparently not ef- 
fective at the same dose levels in differing species of mice. Larionov 
(1967) suggests that  a natural biological product should be more prom- 
ising as a chemotherapeutic agent than a synthetic compound. The 
same author has stated that the maximum effective acceptable dosage 
of an anti-tumor compound is close to the dosage which kills the 
animal, whereas a decrease in dosage, even slight, leads to a sharp 
drop in effectiveness. The narrow threshold is seen here in regard to  
the ineffectiveness of the lower concentrations of Holothurin on the 
Sarcoma 180 tumors, and the lethal effect of 0.20 mg given over a 
period of several alternate days to the tumor-bearing mice. Due to the 
narrow range of effective concentrations of Holothurin in relation to, 
its lethal dose, i t  is likely that the ineffectiveness of Holothurin in the 
C57-Bl-6J mice bearing B-16 melanomas was a reflection of the toler- 
ance to higher doses of Holothurin in these animals. There is no in- 
dication that Holothurin, or any other chemotherapeutic agent, would 
have differing effects in male and female tumor-bearing mice although 
profound metabolic differences between male and female rats and 
mice are well-known (Olmsted 1969). However, the differences seen 
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in this study could also be due to differences in the injection site or in 
the types of tumor. While this consideration presents many variables, 
the Sarcoma 180 tumor grows best in white Swiss mice and the B-16 
melanoma grows best in C57-Bl-6J mice. Further, i t  should be noted 
that the mean survival time of the untreated mice with the two dif- 
ferent types of tumor was about the same, i.e., about 3 to 4 weeks 
after tumor inoculation. The hypothesis is further supported by the 
finding that Holothurin is many times more effective in causing he- 
molysis than saponin when living red blood cells are used in the test 
system. 
Other hemolysis experiments similar to those described here have 
shown that between 0.04 and 0.10 mg of the crude extract of Holo- 
thurin would cause complete hemolysis, while 0.08 to 0.10 mg of sa- 
ponin was required for the same effect (Nigrelli and Jakowska 1960). 
The apparent 40 to 100-fold discrepancy between the findings of Nig- 
relli and Jakowska and the findings of the present study could be ac- 
counted for by the use of different dilutions of red blood cells, or by 
differences in the age of red blood cells used, or by species effects. 
Nigrelli and Jakowska's data suggest that Holothurin is only slightly 
more effective in causing hemolysis than saponin, while in the present 
study using red blood cells that were freshly obtained from mice just 
prior to testing i t  would appear that Holothurin is some 250 to  500 
times more effective than saponin in causing hemolysis. Since a num- 
ber of studies have shown Holothurin to have profound biological ef- 
fects in concentrations as low as 0.01 ppm it is not surprising that 
this biotoxic principle is much more effective than saponin on fresh 
red blood cells. It would therefore appear that the action of Holo- 
thurin involves more than a surface tension lowering effect on living 
cells. 
Because Holothurin is an effective anti-tumor agent at concen- 
trations only slightly lower than the lethal dose, i t  might be tenta- 
tively hypothesized that  Holothurin is acting on some process common 
to all cells, not just tumor cells. However, no studies have been done 
on the metabolic effects of Holothurin. The studies reported here indi- 
cate that the mode of action of Holothurin in retarding tumor growth 
and prolonging life of tumor-bearing mice is probably different from 
the action of a surfactant such as saponin. It is likely that the energy 
requirements of the white Swiss mice with Sarcoma 180 differed from 
those of the C57-Bl-6J mice bearing B-16 melanoma tumors. Other 
studies from this laboratory on the C57-Bl-6J mice with B-16 mela- 
noma tumors have shown that the growth of melanoma tumor occurs 
at the expense of the anabolic processes of the host mouse. Structural 
phospholipids synthesized by the tumor were shown to be derived 
from synthesis in the liver (Terranova, Hardy and Olmsted 1970). 
Although several experiments have been reported in the literature 
regarding saponin, none have shown saponin to have any anti-tumor 
activity in vivo. It is likly that saponin destroys cells simply by its 
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action to lower surface tension starting with the plasma membrane 
and continuing its action on membranes of other cellular constituents 
in proportion to the concentration of saponin used. While the action 
of Holothurin has some yet unknown effect other than, or in addition 
to, its surfactant effect, it  is likely that i t  causes a n  inhibition of an 
active, or energy-dependent, physiological process. 
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